News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
93,951 Results
Type
Article (6812)
Company Profile (41)
Press Release (87098)
Section
Business (28369)
Career Advice (131)
Deals (4116)
Drug Delivery (31)
Drug Development (14336)
Employer Resources (15)
FDA (2893)
Job Trends (2172)
News (50234)
Policy (6081)
Tag
Academia (428)
Allergies (26)
Alliances (9175)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (32)
Approvals (2891)
Artificial intelligence (29)
Bankruptcy (20)
Best Places to Work (1848)
Biosimilars (57)
Biotechnology (27)
Breast cancer (46)
Cancer (355)
Career advice (113)
Cell therapy (74)
Clinical research (11540)
Collaboration (151)
Compensation (29)
COVID-19 (556)
C-suite (37)
Data (309)
Diabetes (26)
Diagnostics (557)
Earnings (9538)
Events (11961)
Executive appointments (89)
FDA (3132)
Funding (109)
Gene therapy (70)
GLP-1 (101)
Government (1305)
Healthcare (1981)
Immunology and inflammation (21)
Infectious disease (581)
Inflammatory bowel disease (42)
IPO (1885)
Job creations (397)
Job search strategy (110)
Layoffs (53)
Legal (561)
Lung cancer (66)
Lymphoma (23)
Manufacturing (88)
Medical device (1218)
Medtech (1219)
Mergers & acquisitions (2299)
Metabolic disorders (60)
Neuroscience (310)
NextGen: Class of 2025 (702)
Non-profit (353)
Northern California (376)
Obesity (22)
Opinion (42)
Peanut (20)
People (8069)
Phase I (3793)
Phase II (4793)
Phase III (4237)
Pipeline (178)
Policy (29)
Postmarket research (300)
Preclinical (1471)
Press Release (66)
Radiopharmaceuticals (36)
Rare diseases (61)
Real estate (933)
Regulatory (4736)
Research institute (391)
Series A (25)
Southern California (392)
Startups (583)
United States (3306)
Vaccines (152)
Date
Last 7 days (133)
Last 30 days (528)
Last 365 days (6616)
2025 (541)
2024 (6665)
2023 (7104)
2022 (9484)
2021 (9781)
2020 (8434)
2019 (5982)
2018 (4607)
2017 (5149)
2016 (4693)
2015 (5419)
2014 (3817)
2013 (2942)
2012 (3029)
2011 (3191)
2010 (2606)
Location
Africa (94)
Asia (7653)
Australia (916)
California (907)
Canada (187)
China (135)
Colorado (33)
Delaware (26)
Europe (13830)
Florida (97)
Illinois (37)
Indiana (34)
Japan (24)
Maryland (282)
Massachusetts (626)
Michigan (23)
Minnesota (39)
New Jersey (347)
New York (243)
North Carolina (174)
Northern California (376)
Ohio (34)
Pennsylvania (147)
South America (134)
Southern California (392)
Texas (103)
Washington State (73)
93,951 Results for "fujifilm kyowa kirin biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company based in Japan, announced that its board of directors has approved plans to invest up to $530 million to build a new, state-of-the-art manufacturing facility in Sanford, North Carolina.
June 10, 2024
·
4 min read
Press Releases
Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies
December 9, 2024
·
2 min read
Press Releases
Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe
January 30, 2025
·
7 min read
Cancer
Kura Signs Leukemia Pact with Kyowa Kirin After Losing Race to Syndax
The agreement will give Kura enough capital to support the development and launch of its menin inhibitor ziftomenib.
November 21, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
December 10, 2024
·
10 min read
Business
How Kyowa Kirin is Giving Employees a Voice in the Company’s Future
Five years ago, Kyowa Kirin set out to expand its North America operations, adding new employees and capabilities at a rapid pace. The Human Resources team ensures employee input is central to managing that growth and nurturing a culture to support it
December 7, 2023
·
4 min read
·
Britt Byers, Senior Vice President of Human Resources, Kyowa Kirin North America
Press Releases
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
November 20, 2024
·
11 min read
Press Releases
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
October 31, 2024
·
3 min read
Business
Kyowa Kirin Pays $100M Upfront to BridgeBio for Skeletal Dysplasias Drug in Japan
Kyowa Kirin’s dealmaking continued on Wednesday when BridgeBio Pharma granted the Japanese company an exclusive license to develop and commercialize infigratinib.
February 8, 2024
·
2 min read
·
Tyler Patchen
Pharm Country
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that data from the pre-clinical pharmacokinetics & efficacy study comparing ocular tissue distribution after ocular instillation of tivozanib eye drops will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held in Seattle, Washington from May 5-9, 2024.
May 8, 2024
·
4 min read
1 of 9,396
Next
